Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ImpediMed.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: ACCC gives the OK for API takeover by Wesfarmers
Experts
ScoPo’s Powerplays: Who’s making a gritty comeback?
Health & Biotech
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021
Health & Biotech
ScoPo’s Powerplays: Neuren breakthrough, M&A deals, and why EBOS ticks ESG boxes
Health & Biotech
ScoPo’s Powerplays: Investors become a ‘little more picky’ as markets continue to push ever higher
News
October Winners Column: The ASX returned to growth and coal, steel, hydrogen and tech all benefited
Health & Biotech
ScoPo’s Powerplays: ‘Light shining bright at the end of the tunnel’ as outlook turns positive for healthcare
Health & Biotech
ScoPo’s Powerplays: Reopening brings previously neglected health stocks into play
Health & Biotech
ScoPo’s Powerplays: All we want for Christmas is a market rally
ScoPo’s Powerplays: ‘Market volatility could lead to a rally by Christmas’
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Health & Biotech
ASX Health Stocks: Invex jumps 14pc after deal in Korea, Noxopharm gets US Patent nod
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ScoPo’s Powerplays: As focus turns to Delta variant, these ASX health stocks are profiting from COVID-19 testing
Health & Biotech
ASX Health Stocks: HeraMed jumps 11pc on survey results, while Acrux seeks FDA approval for acne gel
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech